In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Completing the tissue engineering triangle of cells, signal, and matrix by using bone marrow aspirate concentrates, recombinant human bone morphogenetic protein-2/acellular collagen sponge, and crushed cancellous mineralized allogeneic bone predictably regenerates large volumes of histologically and functionally useful bone in jaw reconstruction. This composite graft is used directly in the patient's recipient site and is known in situ tissue engineering.

Original languageEnglish (US)
Title of host publicationTranslational Regenerative Medicine
PublisherElsevier Inc.
Pages437-447
Number of pages11
ISBN (Print)9780124104570, 9780124103962
DOIs
StatePublished - Dec 2 2014

Fingerprint

Bone Regeneration
Tissue Engineering
Jaw
Bone and Bones
Porifera
Collagen
Bone Marrow
Transplants
recombinant human bone morphogenetic protein-2

Keywords

  • Bone marrow aspirate concentrates
  • In-situ tissue engineering
  • Multipotent stem cells
  • Recombinant human bone morphogenetic protien-2

ASJC Scopus subject areas

  • Medicine(all)

Cite this

In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction. / Marx, Robert.

Translational Regenerative Medicine. Elsevier Inc., 2014. p. 437-447.

Research output: Chapter in Book/Report/Conference proceedingChapter

Marx, Robert. / In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction. Translational Regenerative Medicine. Elsevier Inc., 2014. pp. 437-447
@inbook{1fc2727900cd4844aa8d2b998e700544,
title = "In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction",
abstract = "Completing the tissue engineering triangle of cells, signal, and matrix by using bone marrow aspirate concentrates, recombinant human bone morphogenetic protein-2/acellular collagen sponge, and crushed cancellous mineralized allogeneic bone predictably regenerates large volumes of histologically and functionally useful bone in jaw reconstruction. This composite graft is used directly in the patient's recipient site and is known in situ tissue engineering.",
keywords = "Bone marrow aspirate concentrates, In-situ tissue engineering, Multipotent stem cells, Recombinant human bone morphogenetic protien-2",
author = "Robert Marx",
year = "2014",
month = "12",
day = "2",
doi = "10.1016/B978-0-12-410396-2.00031-1",
language = "English (US)",
isbn = "9780124104570",
pages = "437--447",
booktitle = "Translational Regenerative Medicine",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction

AU - Marx, Robert

PY - 2014/12/2

Y1 - 2014/12/2

N2 - Completing the tissue engineering triangle of cells, signal, and matrix by using bone marrow aspirate concentrates, recombinant human bone morphogenetic protein-2/acellular collagen sponge, and crushed cancellous mineralized allogeneic bone predictably regenerates large volumes of histologically and functionally useful bone in jaw reconstruction. This composite graft is used directly in the patient's recipient site and is known in situ tissue engineering.

AB - Completing the tissue engineering triangle of cells, signal, and matrix by using bone marrow aspirate concentrates, recombinant human bone morphogenetic protein-2/acellular collagen sponge, and crushed cancellous mineralized allogeneic bone predictably regenerates large volumes of histologically and functionally useful bone in jaw reconstruction. This composite graft is used directly in the patient's recipient site and is known in situ tissue engineering.

KW - Bone marrow aspirate concentrates

KW - In-situ tissue engineering

KW - Multipotent stem cells

KW - Recombinant human bone morphogenetic protien-2

UR - http://www.scopus.com/inward/record.url?scp=84942803266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942803266&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-410396-2.00031-1

DO - 10.1016/B978-0-12-410396-2.00031-1

M3 - Chapter

SN - 9780124104570

SN - 9780124103962

SP - 437

EP - 447

BT - Translational Regenerative Medicine

PB - Elsevier Inc.

ER -